Dr Anne Beal
Independent Non-Executive Director
Anne was appointed as an Independent Non-Executive Director on 6 May 2021.
Skills and experience
Anne brings extensive healthcare experience to the Board as a physician and entrepreneur combined with a passion for patient advocacy. She is a recognised health policy expert in the development of global and national programmes for improving healthcare access for all patient groups and in ensuring the voice of patients is reflected in research programmes.
Prior to her current roles, Anne spent six years at Harvard Medical School and Massachusetts General Hospital, where she was an instructor in paediatrics. She has also held leadership roles at the Commonwealth Fund and the Aetna Foundation. Anne was previously Deputy Executive Director and Chief Engagement Officer for The Patient-Centered Outcomes Research Institute in the U.S. and Chief Patient Officer and Global Head of Patient Solutions at Sanofi.
External Appointments
- Founder and CEO, AbsoluteJOI Skincare
- Board Member, AcademyHealth
- Board Member, Prolacta Bioscience
Find out more
-
Role of the Board
The Board is accountable to shareholders for ensuring that GSK is appropriately managed and achieves the strategic objectives it sets
-
Independence of Non-Executive Directors
Our Board considers all of its Non-Executive Directors to be independent in character and judgement
-
The roles of our Chair and Chief Executive Officer
Sir Jonathan Symonds is the Chair of our Board and Emma Walmsley is our Chief Executive Officer (CEO).
-
About GSK
We research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
